Clinical trial
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With…
NCT00128622 · H. Kim Lyerly, Other · Completed
Key facts
| NCT number | NCT00128622 |
|---|---|
| Title | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer |
| Official title | A Phase I Study of Regulatory T Cell Depletion With Denileukin Diftitox Followed by Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox-Tricom in Patients With Advanced or Metastatic Malignancies Expressing CEA |
| Lead sponsor | H. Kim Lyerly, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | denileukin diftitox, recombinant fowlpox-CEA(6D)/TRICOM vaccine, therapeutic autologous dendritic cells |
| Enrollment | 24 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Aug 10, 2005 |
| Last update posted | Nov 12, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: